NANO ANTIBODY AND USE THEREOF

Provided is a nano antibody, the amino acid sequence thereof being EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO:1), wherein X1 is selected from Y or F, and X2 is selected from F or L. The antibody can be used t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: QIN, Yaobin, YANG, Jianfeng, SONG, Zhe, ZHANG, Lei, LI, Xianggan, DONG, Qiuping, ZHU, Zhiwei, LI, Yuejin, QI, Youlin, HOU, Limin, WANG, Jinyu
Format: Patent
Sprache:chi ; eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator QIN, Yaobin
YANG, Jianfeng
SONG, Zhe
ZHANG, Lei
LI, Xianggan
DONG, Qiuping
ZHU, Zhiwei
LI, Yuejin
QI, Youlin
HOU, Limin
WANG, Jinyu
description Provided is a nano antibody, the amino acid sequence thereof being EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO:1), wherein X1 is selected from Y or F, and X2 is selected from F or L. The antibody can be used to dissolve Charcot-Leyden crystals (CLCs), thereby reducing pulmonary inflammation, changes in lung function, and mucus production. Further provided is the use of the nano antibody in the preparation of a drug and a reagent for detecting Charcot-Leyden crystals (CLCs) and/or Galectin-10 protein. L'invention concerne un nanoanticorps dont la séquence d'acides aminés est EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO : 1), dans laquelle X1 est choisi parmi Y ou F, et X2 est choisi parmi F ou L. L'anticorps peut être utilisé pour dissoudre des cristaux de Charcot-Leyden (CLC), ce qui permet de réduire l'inflammation pulmonaire, les
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021223079A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021223079A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021223079A13</originalsourceid><addsrcrecordid>eNrjZJD1c_TzV3D0C_F08neJBDJcFEKDXRVCPFyDXP3deBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGRoZGRsYG5paOhMXGqAP4PIb8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NANO ANTIBODY AND USE THEREOF</title><source>esp@cenet</source><creator>QIN, Yaobin ; YANG, Jianfeng ; SONG, Zhe ; ZHANG, Lei ; LI, Xianggan ; DONG, Qiuping ; ZHU, Zhiwei ; LI, Yuejin ; QI, Youlin ; HOU, Limin ; WANG, Jinyu</creator><creatorcontrib>QIN, Yaobin ; YANG, Jianfeng ; SONG, Zhe ; ZHANG, Lei ; LI, Xianggan ; DONG, Qiuping ; ZHU, Zhiwei ; LI, Yuejin ; QI, Youlin ; HOU, Limin ; WANG, Jinyu</creatorcontrib><description>Provided is a nano antibody, the amino acid sequence thereof being EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO:1), wherein X1 is selected from Y or F, and X2 is selected from F or L. The antibody can be used to dissolve Charcot-Leyden crystals (CLCs), thereby reducing pulmonary inflammation, changes in lung function, and mucus production. Further provided is the use of the nano antibody in the preparation of a drug and a reagent for detecting Charcot-Leyden crystals (CLCs) and/or Galectin-10 protein. L'invention concerne un nanoanticorps dont la séquence d'acides aminés est EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO : 1), dans laquelle X1 est choisi parmi Y ou F, et X2 est choisi parmi F ou L. L'anticorps peut être utilisé pour dissoudre des cristaux de Charcot-Leyden (CLC), ce qui permet de réduire l'inflammation pulmonaire, les</description><language>chi ; eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211111&amp;DB=EPODOC&amp;CC=WO&amp;NR=2021223079A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211111&amp;DB=EPODOC&amp;CC=WO&amp;NR=2021223079A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QIN, Yaobin</creatorcontrib><creatorcontrib>YANG, Jianfeng</creatorcontrib><creatorcontrib>SONG, Zhe</creatorcontrib><creatorcontrib>ZHANG, Lei</creatorcontrib><creatorcontrib>LI, Xianggan</creatorcontrib><creatorcontrib>DONG, Qiuping</creatorcontrib><creatorcontrib>ZHU, Zhiwei</creatorcontrib><creatorcontrib>LI, Yuejin</creatorcontrib><creatorcontrib>QI, Youlin</creatorcontrib><creatorcontrib>HOU, Limin</creatorcontrib><creatorcontrib>WANG, Jinyu</creatorcontrib><title>NANO ANTIBODY AND USE THEREOF</title><description>Provided is a nano antibody, the amino acid sequence thereof being EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO:1), wherein X1 is selected from Y or F, and X2 is selected from F or L. The antibody can be used to dissolve Charcot-Leyden crystals (CLCs), thereby reducing pulmonary inflammation, changes in lung function, and mucus production. Further provided is the use of the nano antibody in the preparation of a drug and a reagent for detecting Charcot-Leyden crystals (CLCs) and/or Galectin-10 protein. L'invention concerne un nanoanticorps dont la séquence d'acides aminés est EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO : 1), dans laquelle X1 est choisi parmi Y ou F, et X2 est choisi parmi F ou L. L'anticorps peut être utilisé pour dissoudre des cristaux de Charcot-Leyden (CLC), ce qui permet de réduire l'inflammation pulmonaire, les</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD1c_TzV3D0C_F08neJBDJcFEKDXRVCPFyDXP3deBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGRoZGRsYG5paOhMXGqAP4PIb8</recordid><startdate>20211111</startdate><enddate>20211111</enddate><creator>QIN, Yaobin</creator><creator>YANG, Jianfeng</creator><creator>SONG, Zhe</creator><creator>ZHANG, Lei</creator><creator>LI, Xianggan</creator><creator>DONG, Qiuping</creator><creator>ZHU, Zhiwei</creator><creator>LI, Yuejin</creator><creator>QI, Youlin</creator><creator>HOU, Limin</creator><creator>WANG, Jinyu</creator><scope>EVB</scope></search><sort><creationdate>20211111</creationdate><title>NANO ANTIBODY AND USE THEREOF</title><author>QIN, Yaobin ; YANG, Jianfeng ; SONG, Zhe ; ZHANG, Lei ; LI, Xianggan ; DONG, Qiuping ; ZHU, Zhiwei ; LI, Yuejin ; QI, Youlin ; HOU, Limin ; WANG, Jinyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021223079A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng ; fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>QIN, Yaobin</creatorcontrib><creatorcontrib>YANG, Jianfeng</creatorcontrib><creatorcontrib>SONG, Zhe</creatorcontrib><creatorcontrib>ZHANG, Lei</creatorcontrib><creatorcontrib>LI, Xianggan</creatorcontrib><creatorcontrib>DONG, Qiuping</creatorcontrib><creatorcontrib>ZHU, Zhiwei</creatorcontrib><creatorcontrib>LI, Yuejin</creatorcontrib><creatorcontrib>QI, Youlin</creatorcontrib><creatorcontrib>HOU, Limin</creatorcontrib><creatorcontrib>WANG, Jinyu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QIN, Yaobin</au><au>YANG, Jianfeng</au><au>SONG, Zhe</au><au>ZHANG, Lei</au><au>LI, Xianggan</au><au>DONG, Qiuping</au><au>ZHU, Zhiwei</au><au>LI, Yuejin</au><au>QI, Youlin</au><au>HOU, Limin</au><au>WANG, Jinyu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NANO ANTIBODY AND USE THEREOF</title><date>2021-11-11</date><risdate>2021</risdate><abstract>Provided is a nano antibody, the amino acid sequence thereof being EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO:1), wherein X1 is selected from Y or F, and X2 is selected from F or L. The antibody can be used to dissolve Charcot-Leyden crystals (CLCs), thereby reducing pulmonary inflammation, changes in lung function, and mucus production. Further provided is the use of the nano antibody in the preparation of a drug and a reagent for detecting Charcot-Leyden crystals (CLCs) and/or Galectin-10 protein. L'invention concerne un nanoanticorps dont la séquence d'acides aminés est EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO : 1), dans laquelle X1 est choisi parmi Y ou F, et X2 est choisi parmi F ou L. L'anticorps peut être utilisé pour dissoudre des cristaux de Charcot-Leyden (CLC), ce qui permet de réduire l'inflammation pulmonaire, les</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng ; fre
recordid cdi_epo_espacenet_WO2021223079A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
title NANO ANTIBODY AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A12%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QIN,%20Yaobin&rft.date=2021-11-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021223079A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true